| scholarly article | Q13442814 |
| P50 | author | Gerald T. Keusch | Q59729805 |
| P2093 | author name string | A Donohue-Rolfe | |
| D Thorley-Lawson | |||
| M Jacewicz | |||
| C Edson | |||
| P2860 | cites work | Quantitative microassay in cell culture for enterotoxin of Shigella dysenteriae | Q69172748 |
| The pathogenesis of shigella diarrhea. II. Enterotoxin-induced acute enteritis in the rabbit ileum | Q69183657 | ||
| Serum enterotoxin-neutralizing antibody in human shigellosis | Q69254226 | ||
| Pathogenesis of experimental cholera: biologic ativities of purified procholeragen A | Q69985914 | ||
| Animal toxicity of Shigella dysenteriae cytotoxin: evidence that the neurotoxic, enterotoxic, and cytotoxic activities are due to one toxin | Q70237191 | ||
| Production of Shigella dysenteriae type 1-like cytotoxin by Escherichia coli | Q71454940 | ||
| The cytotoxic activity of Shigella toxin. Evidence for catalytic inactivation of the 60 S ribosomal subunit | Q71855282 | ||
| Continuous cultures of fused cells secreting antibody of predefined specificity | Q26776979 | ||
| “Western Blotting”: Electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A | Q28131712 | ||
| Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity | Q29618557 | ||
| Characterization of Shigella dysenteriae 1 (Shiga) toxin purified by anti-Shiga toxin affinity chromatography | Q33909058 | ||
| The pathogenesis of Shigella diarrhea. I. Enterotoxin production by Shigella dysenteriae I. | Q34069456 | ||
| Biological properties of Shigella flexneri 2A toxin and its serological relationship to Shigella dysenteriae 1 toxin | Q34427225 | ||
| Pathogenesis of shigella diarrhea. VII. Evidence for a cell membrane toxin receptor involving β1 {arrow} 4-linked N-acetyl-D-glucosamine oligomers | Q36335732 | ||
| Purification and characterization of a Shigella dysenteriae 1-like toxin produced by Escherichia coli | Q37112219 | ||
| Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A | Q39513417 | ||
| Cross-linking of the components of lactose synthetase with dimethylpimelimidate | Q40306392 | ||
| Shigella toxin(s): description and role in diarrhea and dysentery | Q40334884 | ||
| The Pathogenesis of Shigella Diarrhea. VI. Toxin and Antitoxin in Shigella flexneri and Shigella sonnei Infections in Humans | Q40765959 | ||
| Texas Star-SR: attenuated "Vibrio cholerae" oral vaccine candidate | Q40838743 | ||
| Restriction in Vivo III. General effects of glucosylation and restriction on phage T4 gene expression and replication | Q41073253 | ||
| Primary amines and chloroquine inhibit cytotoxic responses to Shigella toxin and permit late antibody rescue of toxin treated cells | Q41919212 | ||
| Pathogenesis of Shigella diarrhea. VIII. Evidence for a translocation step in the cytotoxic action of Shiga toxin. | Q41920524 | ||
| PREPARATION AND PROPERTIES OF SHIGA TOXIN AND TOXOID. | Q42817207 | ||
| Subunit structure of Shigella cytotoxin. | Q50938170 | ||
| Isolation and characterization of Shigella shigae cytotoxin. | Q54559095 | ||
| ENVIRONMENTAL AND HUMAN ISOLATES OF VIBRIO CHOLERAE AND VIBRIO PARAHAEMOLYTICUS PRODUCE A SHIGELLA DYSENTERIAE 1 (SHIGA)-LIKE CYTOTOXIN | Q57563917 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | diarrhea | Q40878 |
| antibody | Q79460 | ||
| pathogenesis | Q372016 | ||
| P304 | page(s) | 1767-1781 | |
| P577 | publication date | 1984-12-01 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | Pathogenesis of Shigella diarrhea. IX. Simplified high yield purification of Shigella toxin and characterization of subunit composition and function by the use of subunit-specific monoclonal and polyclonal antibodies | |
| P478 | volume | 160 |
| Q35104239 | A system for production and rapid purification of large amounts of the Shiga toxin/Shiga-like toxin I B subunit |
| Q35109009 | Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II |
| Q33877305 | Antibody-based protection of gnotobiotic piglets infected with Escherichia coli O157:H7 against systemic complications associated with Shiga toxin 2. |
| Q54545661 | Bacteriophage control of Shiga toxin 1 production and release by Escherichia coli. |
| Q44491228 | Beta2-adrenoceptor activation inhibits Shiga toxin2-induced apoptosis of renal tubular epithelial cells. |
| Q42859529 | Characterization of Shiga-like toxin I B subunit purified from overproducing clones of the SLT-I B cistron |
| Q37031424 | Characterization of monoclonal antibodies against Shiga-like toxin from Escherichia coli |
| Q36215407 | Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine |
| Q36194407 | Cloning and sequencing of the genes for Shiga toxin from Shigella dysenteriae type 1. |
| Q35548775 | Coexpression of the B subunit of Shiga toxin 1 and EaeA from enterohemorrhagic Escherichia coli in Vibrio cholerae vaccine strains |
| Q42913459 | Comparative analysis of the abilities of Shiga toxins 1 and 2 to bind to and influence neutrophil apoptosis |
| Q33346383 | Comparison of Shiga toxin production by hemolytic-uremic syndrome-associated and bovine-associated Shiga toxin-producing Escherichia coli isolates. |
| Q34527617 | Comparison of Shiga-like toxin I B-subunit expression and localization in Escherichia coli and Vibrio cholerae by using trc or iron-regulated promoter systems |
| Q51680443 | Comparison of Shiga-like toxin II expression between two genetically diverse lineages of Escherichia coli O157:H7. |
| Q33801217 | Comparison of binding platforms yields insights into receptor binding differences between shiga toxins 1 and 2 |
| Q35566514 | Comparison of single-dose treatment with norfloxacin and standard 5-day treatment with trimethoprim-sulfamethoxazole for acute shigellosis in adults |
| Q36977977 | Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants |
| Q33605233 | Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice |
| Q37276634 | Comparison of two label-free global quantitation methods, APEX and 2D gel electrophoresis, applied to the Shigella dysenteriae proteome |
| Q36949679 | Construction of stable LamB-Shiga toxin B subunit hybrids: analysis of expression in Salmonella typhimurium aroA strains and stimulation of B subunit-specific mucosal and serum antibody responses |
| Q33375457 | Current views on aetiology and management of haemolytic uraemic syndrome |
| Q33337469 | Effect of Shiga toxin and Shiga-like toxins on eukaryotic cells |
| Q40754536 | Engineered human vaccines |
| Q36195757 | Enterotoxins in acute infective diarrhoea |
| Q37207255 | Enzyme-linked immunosorbent assay for shigella toxin. |
| Q24651553 | Evidence that glutamic acid 167 is an active-site residue of Shiga-like toxin I |
| Q26852693 | Exploiting dendrimer multivalency to combat emerging and re-emerging infectious diseases |
| Q35381150 | Expression and purification of Shiga-like toxin II B subunits. |
| Q35199053 | Glycolipid binding preferences of Shiga toxin variants |
| Q40208572 | HeLa cell adherence and cytotoxin production by enteropathogenic Escherichia coli isolated from infants with diarrhea in Thailand |
| Q35423953 | Heterologous antigen expression in Vibrio cholerae vector strains |
| Q33340641 | Human Stx2-specific monoclonal antibodies prevent systemic complications of Escherichia coli O157:H7 infection |
| Q35592357 | Implication of virulence factors in Escherichia coil O157:H7 pathogenesis |
| Q37006892 | In vivo formation of hybrid toxins comprising Shiga toxin and the Shiga-like toxins and role of the B subunit in localization and cytotoxic activity |
| Q36634680 | Infection by verocytotoxin-producing Escherichia coli |
| Q36329665 | Interaction between Shiga toxin and monoclonal antibodies: binding characteristics and in vitro neutralizing abilities. |
| Q40162448 | Ionic requirements for entry of Shiga toxin from Shigella dysenteriae 1 into cells |
| Q37156797 | Isolation and characterization of monoclonal antibodies to Shiga-like toxin II of enterohemorrhagic Escherichia coli and use of the monoclonal antibodies in a colony enzyme-linked immunosorbent assay |
| Q38342112 | Kinetic Analyses of Bindings of Shiga-like Toxin to Clustered and Dispersed Gb3 Glyco-Arrays on a Quartz-Crystal Microbalance |
| Q55324511 | LPS-primed CD11b+ leukocytes serve as an effective carrier of Shiga toxin 2 to cause hemolytic uremic syndrome in mice. |
| Q40002237 | Latrunculin B facilitates Shiga toxin 1 transcellular transcytosis across T84 intestinal epithelial cells |
| Q33328565 | Localization of verotoxin receptors in nervous system. |
| Q35762828 | Maturational regulation of globotriaosylceramide, the Shiga-like toxin 1 receptor, in cultured human gut epithelial cells |
| Q27666433 | Molecular Basis of Differential B-Pentamer Stability of Shiga Toxins 1 and 2 |
| Q36099489 | Monoclonal antibodies and toxins--a perspective on function and isotype |
| Q35459501 | Monoclonal antibodies specific for the bundle-forming pilus of enteropathogenic Escherichia coli |
| Q35227896 | Monoclonal antibodies to the enterotoxin of Bacteroides fragilis: production, characterization, and immunodiagnostic application. |
| Q35836549 | Morphologic evaluation of the effects of Shiga toxin and E coli Shiga-like toxin on the rabbit intestine |
| Q38303627 | Nasal immunization with E. coli verotoxin 1 (VT1)-B subunit and a nontoxic mutant of cholera toxin elicits serum neutralizing antibodies |
| Q30434555 | New developments in enteric bacterial toxins |
| Q36265701 | Nucleotide sequence and promoter mapping of the Escherichia coli Shiga-like toxin operon of bacteriophage H-19B. |
| Q34633814 | Nucleotide sequence of the Shiga-like toxin genes of Escherichia coli |
| Q33419782 | Overview and Historical Perspectives |
| Q24550740 | Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections |
| Q34578986 | Pathogenesis of Shigella diarrhea. XVI. Selective targetting of Shiga toxin to villus cells of rabbit jejunum explains the effect of the toxin on intestinal electrolyte transport |
| Q37026722 | Pathogenesis of Shigella diarrhea: rabbit intestinal cell microvillus membrane binding site for Shigella toxin |
| Q38350915 | Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide |
| Q40150192 | Physicochemical and biological properties of purified Escherichia coli Shiga-like toxin II variant. |
| Q33344261 | Production and characterization of protective human antibodies against Shiga toxin 1 |
| Q46841076 | Protection of mice from Shiga toxin-2 toxemia by mucosal vaccine of Shiga toxin 2B-His with Escherichia coli enterotoxin |
| Q40856041 | Protein toxins acting on intracellular targets: cellular uptake and translocation to the cytosol |
| Q40154038 | Purification and characterization of an Escherichia coli Shiga-like toxin II variant |
| Q37007284 | Purification of Shiga toxin and Shiga-like toxins I and II by receptor analog affinity chromatography with immobilized P1 glycoprotein and production of cross-reactive monoclonal antibodies |
| Q53224717 | Recombinant Shiga toxin B subunit elicits protection against Shiga toxin via mixed Th type immune response in mice. |
| Q33495149 | Regulation of the Shiga-like toxin II operon in Escherichia coli |
| Q34363235 | Role of iron in regulation of virulence genes |
| Q35966752 | Roles of a ribosome-binding site and mRNA secondary structure in differential expression of Shiga toxin genes |
| Q40429422 | Secretory immunoglobulin A response to Shiga toxin in rabbits: kinetics of the initial mucosal immune response and inhibition of toxicity in vitro and in vivo |
| Q70250091 | Selective destruction of vagal sensory neurons using Shigella cytotoxin |
| Q38361388 | Self-assembled monolayers of globotriaosylceramide (Gb3) mimics: surface-specific affinity with shiga toxins |
| Q36973479 | Serological responses to the B subunit of Shiga-like toxin 1 and its peptide fragments indicate that the B subunit is a vaccine candidate to counter action of the toxin |
| Q37293251 | Shiga Toxin Mediated Neurologic Changes in Murine Model of Disease. |
| Q37063416 | Shiga and Shiga-like toxins |
| Q70250089 | Shiga toxin as inhibitor of protein synthesis |
| Q39699154 | Shiga toxin is transported into the nucleoli of intestinal epithelial cells via a carrier-dependent process |
| Q68041265 | Shiga toxin: production and purification |
| Q72362103 | Stimulation of gastrointestinal antibody to Shiga toxin by orogastric immunization in mice |
| Q40158183 | Synthetic peptides of Shiga toxin B subunit induce antibodies which neutralize its biological activity |
| Q38640768 | The Epinephrine/Norepinephrine/Autoinducer-3 Interkingdom Signaling System in Escherichia coli O157:H7. |
| Q33504952 | The detection of Shiga toxins in the kidney of a patient with hemolytic uremic syndrome |
| Q33398109 | The expression of blood group P1 in post-enteropathic haemolytic uraemic syndrome |
| Q42856082 | The mode of action of Shiga toxin on peptide elongation of eukaryotic protein synthesis |
| Q36303500 | The pathogenesis of edema disease in pigs. A review |
| Q54648744 | The role of tyrosine-114 in the enzymatic activity of the Shiga-like toxin I A-chain. |
| Q37608531 | Transcription of the Shiga-like toxin type II and Shiga-like toxin type II variant operons of Escherichia coli |
| Q30441434 | p38 mitogen-activated protein kinase mediates lipopolysaccharide and tumor necrosis factor alpha induction of shiga toxin 2 sensitivity in human umbilical vein endothelial cells |
Search more.